60 DEGREES PHARMACEUTICALS, INC.

SXTP

60 DEGREES PHARMACEUTICALS, INC.

SXTP

Insider Sentiment (TTM):

Last Purchase:2026-06-12Last Sale:-Shares Purchased (TTM):20,633Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:194,270Shares Outstanding:1,725,758Institutional Ownership Pct.:11.26%

Earnings Market Reaction:

Filing Date:2026-08-14Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash	-	-	-	-	-	-	-	-	-	-	2	2
Cash And Cash Equivalents At Carrying Value	1	3	2	4	2	3	2	3	2	3	2	2
Accounts Receivable Net Current	1	0	1	1	0	0	0	0	0	0	0	0
Other Prepaid Expense Current	-	-	-	-	-	-	-	-	-	-	4	6
Prepaid Expense And Other Assets Current	1	2	1	1	1	1	1	1	1	4	4	-
Deferred Offering Costs	-	-	-	-	-	-	-	-	0	-	-	-
Short Term Investments	-	-	1	0	0	-	2	2	-	-	-	-
Inventory Net	1	1	1	1	1	1	0	0	0	0	0	1
Assets Current	4	6	5	6	4	6	5	7	4	8	7	9
Property Plant And Equipment Net	0	0	0	0	0	0	0	0	0	0	0	0
Other Assets Noncurrent
Prepaid Expense Noncurrent	-	-	0	0	0	0	0	0	0	0	0	-
Other Assets
Operating Lease Right Of Use Asset	-	-	-	-	-	-	-	-	-	-	0	0
Intangible Assets Net Excluding Goodwill	0	0	0	0	0	0	0	0	0	0	0	0
Other Assets Noncurrent	0	0	0	0	0	0	0	0	0	0	0	0
Assets	4	7	5	7	4	6	6	7	4	8	8	9
Liabilities And Stockhold…
Liabilities Current
Accounts Payable And Accrued Liabilities Current	1	1	1	1	1	1	1	1	1	1	1	0
Operating Lease Liability Current	-	-	-	-	-	-	-	-	-	-	0	0
Secured Debt Current	-	-	0	-	-	-	0	-	-	-	-	-
Derivative Liabilities Current	0	0	0	1	1	1	1	1	1	1	2	2
Liabilities Current	2	2	2	2	2	2	2	1	1	1	3	2
Liabilities Noncurrent
Secured Long Term Debt	-	-	0	-	-	-	0	-	-	-	-	-
Liabilities Noncurrent	0	0	0	0	0	0	0	0	0	0	0	0
Liabilities	2	2	2	2	2	2	2	1	1	1	3	3
Stockholders Equity
Preferred Stock Value	10	10	10	10	10	10	10	10	10	10	10	10
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	45	45	42	41	37	37	35	35	29	29	27	27
Accumulated Other Comprehensive Income Loss Net Of…	0	0	0	0	0	0	0	0	0	0	0	0
Retained Earnings Accumulated Deficit	-52	-50	-48	-46	-44	-42	-41	-38	-36	-32	-33	-31
Stockholders Equity	3	5	3	4	2	4	4	6	3	7	5	7
Minority Interest	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0
Liabilities And Stockholders Equity	4	7	5	7	4	6	6	7	4	8	8	9
Series A Preferred Stock	-	0	0	-0	0	0	0	-0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	-
Common Stock Shares Authorized	150	150	150	150	150	150	150	150	150	150	150	-
Common Class A	-	-	-	-	-	-	-	-	-	-	0	-
Common Stock Shares Issued	3	3	1	4	1	1	0	2	1	12	0	-
Shares Outstanding	3	3	1	4	1	7	0	2	1	12	0	-
Preferred Stock Par Or Stated Value Per Share	-	-	-	-	-	-	-	-	-	-	0	0
Preferred Stock Shares Authorized	-	-	-	-	-	-	-	-	-	-	1	1
Preferred Stock Shares Issued	-	-	-	-	-	-	-	-	-	-	0	0
Preferred Stock Shares Outstanding	-	-	-	-	-	-	-	-	-	-	0	0

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	2.16%	23.02%	-15.83%	-	-	-	-	-	-	-	-	-
2025	35.81%	10.70%	-38.14%	4.44%	5.19%	0.74%	-16.84%	-55.90%	-11.32%	7.95%	-1.99%	8.61%
2024	64.79%	9.86%	-36.15%	2.26%	-21.80%	-41.13%	21.05%	43.16%	-23.58%	73.63%	35.71%	21.43%
2023	-	-	-	-23.97%	-48.63%	-60.96%	10.08%	55.12%	-54.49%	-12.50%	15.81%	3.68%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	2.32	3.34	2.66	2.87	2.27	3.13	3.25	5.26	3.09	7.16	2.55	3.58
Quick Ratio	0.99	1.96	1.77	2.18	1.34	2.19	2.34	4.07	1.54	2.91	0.84	3.34
Working Capital	2.13M	4.38M	3.05M	4.11M	2.15M	3.85M	3.73M	5.58M	2.54M	6.80M	4.41M	6.41M
Leverage & Debt
Debt to Equity	0.69	0.43	0.59	0.53	0.76	0.48	0.46	0.24	0.45	0.18	0.62	0.40
Interest Coverage TTM	-1,134.64	-1,072.74	-994.05	-1,287.75	-1,305.30	-1,239.00	-1,227.90	-9.10	-8.30	-2.84	-	-
Debt Ratio	0.41	0.30	0.37	0.35	0.44	0.33	0.31	0.20	0.32	0.15	0.38	0.29
Efficiency & Turnover
Asset Turnover TTM	0.26	0.16	0.18	0.13	0.15	0.09	0.09	0.06	0.07	0.04	-	-
Days Sales Outstanding TTM	141.61	149.79	180.85	192.97	168.27	220.62	215.69	165.66	181.28	321.28	-	-
Receivables Turnover TTM	2.58	2.44	2.02	1.89	2.17	1.65	1.69	2.20	2.01	1.14	-	-
Per Share Metrics
Diluted EPS TTM	-3.25	-4.75	-11.73	-2.17	-20.90	-31.60	-69.99	-4.99	-21.68	-20.49	-	-
Free Cash Flow Per Share TTM	-2.93	-4.73	-10.43	-1.43	-13.12	-19.36	-50.68	-8.68	-31.05	-34.11	-	-
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	-
Margin Metrics
Gross Profit Margin TTM	19.42%	20.90%	22.26%	17.44%	44.95%	41.00%	36.67%	4.47%	-4.92%	-50.31%	-	-
Operating Profit Margin TTM	-774.76%	-791.09%	-771.64%	-837.97%	-1,200.67%	-1,545.37%	-1,599.01%	-2,062.67%	-2,330.61%	-1,808.51%	-	-
Net Profit Margin TTM	-775.24%	-815.76%	-781.63%	-845.59%	-1,200.06%	-1,524.03%	-1,309.41%	-2,109.89%	-1,036.27%	-962.29%	-	-
Growth Metrics
Net Revenue Growth (1Y)	73.21%	50.88%	65.49%	85.48%	51.03%	85.24%	-	-	-	-	-	-
Net Income Growth (1Y)	11.89%	-19.24%	-1.21%	-25.66%	74.90%	193.37%	-	-	-	-	-	-
EPS Growth (1Y)	-84.47%	-84.98%	-83.25%	-90.12%	-3.60%	54.28%	-	-	-	-	-	-
Valuation Metrics
P/E TTM	-0.54	-0.37	-0.17	-2.73	-0.45	-0.23	-0.37	-1.14	-2.80	-3.06	-	-
P/B TTM	1.85	0.64	0.40	4.91	1.44	0.59	0.74	2.05	4.06	1.48	3.38	12.21
P/S TTM	4.20	3.01	1.35	23.06	5.44	3.55	4.83	24.01	29.02	29.43	-	-
Market Cap	4.67M	3.02M	1.36M	21.76M	3.49M	2.36M	2.93M	12.22M	12.32M	10.57M	16.23M	79.60M
Enterprise Value	3.65M	-317.68K	4.58K	17.64M	1.52M	-1.09M	1.43M	8.92M	10.75M	7.68M	14.09M	77.38M
Calculated Values
Free Cash Flow TTM	-7.78M	-8.16M	-6.99M	-5.25M	-4.83M	-6.21M	-5.76M	-4.24M	-6.30M	-5.76M	-	-
Net Debt	-1.02M	-3.34M	-1.36M	-4.12M	-1.97M	-3.45M	-1.50M	-3.30M	-1.58M	-2.89M	-2.14M	-2.22M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-12Purchase

Owner: Dow, Geoffrey S

Title: President and CEO

Shares: 7,350

Price/Share: $1.38

Value: $10,143.00

Shares Owned: 24,131

Relationship: Director,Officer

Ownership: Direct

2025-12-15Purchase

Owner: Dow, Geoffrey S

Title: President and CEO

Shares: 9,670

Price/Share: $0.80

Value: $7,736.00

Shares Owned: 59,618

Relationship: Director,Officer

Ownership: Direct

2025-12-11Purchase

Owner: Dow, Geoffrey S

Title: President and CEO

Shares: 3,613

Price/Share: $0.92

Value: $3,323.96

Shares Owned: 49,948

Relationship: Director,Officer

Ownership: Direct

2025-06-03Purchase

Owner: Xu, Cheryl

Title: -

Shares: 5,000

Price/Share: $2.88

Value: $14,400.00

Shares Owned: 15,816

Relationship: Director

Ownership: Direct

2024-12-16Purchase

Owner: Xu, Cheryl

Title: -

Shares: 2,000

Price/Share: $1.45

Value: $2,900.00

Shares Owned: 54,078

Relationship: Director

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-12	Dow, Geoffrey S	Director,Officer	President and CEO	Direct	Purchase	7,350	1.38	$10,143.00	24,131	4
2025-12-15	Dow, Geoffrey S	Director,Officer	President and CEO	Direct	Purchase	9,670	0.80	$7,736.00	59,618	4
2025-12-11	Dow, Geoffrey S	Director,Officer	President and CEO	Direct	Purchase	3,613	0.92	$3,323.96	49,948	4
2025-06-03	Xu, Cheryl	Director	-	Direct	Purchase	5,000	2.88	$14,400.00	15,816	4
2024-12-16	Xu, Cheryl	Director	-	Direct	Purchase	2,000	1.45	$2,900.00	54,078	4
2024-12-09	Dow, Geoffrey S	Director,Officer	President and CEO	Direct	Purchase	35,823	1.27	$45,495.21	94,580	4
2024-11-21	Dow, Geoffrey S	Director,Officer	President and CEO	Direct	Purchase	3,500	0.91	$3,185.00	20,629	4
2024-08-27	Xu, Cheryl	Director	-	Direct	Purchase	5,000	1.70	$8,500.00	41,078	4
2024-01-31	Dow, Geoffrey S	Director,Officer	President and CEO	Direct	Purchase	25,974	0.38	$9,870.12	703,599	4
2024-01-31	Xu, Cheryl	Director	-	Direct	Purchase	200,000	0.38	$76,000.00	424,934	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

11.26%

Inst. Shares: 194,270

Shares Outstanding: 1,725,758

2025-12-31

6.62%

Inst. Shares: 44,358

Shares Outstanding: 670,211

2025-09-30

1.16%

Inst. Shares: 42,595

Shares Outstanding: 3,675,407

2025-06-30

1.03%

Inst. Shares: 15,141

Shares Outstanding: 1,472,891

2025-03-31

9.36%

Inst. Shares: 30,049

Shares Outstanding: 320,890

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	194,270	1,725,758	11.26%
2025-12-31	44,358	670,211	6.62%
2025-09-30	42,595	3,675,407	1.16%
2025-06-30	15,141	1,472,891	1.03%
2025-03-31	30,049	320,890	9.36%
2024-12-31	139,916	113,665	123.10%
2024-09-30	20,273	488,654	4.15%
2024-06-30	287,200	202,967	141.50%
2024-03-31	413,408	168,756	244.97%
2023-12-31	462,716	66,314	-
2023-09-30	632,518	448,174	141.13%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

60 DEGREES PHARMACEUTICALS, INC. (SXTP) — SEC Financial Statements & Analysis

60 DEGREES PHARMACEUTICALS, INC. (SXTP) is a pharmaceutical preparations company, incorporated in DE. 60 DEGREES PHARMACEUTICALS, INC. trades on Nasdaq as: SXTP, SXTPW. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), 60 DEGREES PHARMACEUTICALS, INC. reported a 73.21% year-over-year revenue growth, a Gross Profit Margin of 19.42% (TTM), a Debt-to-Equity ratio of 0.69x, a Price-to-Sales (P/S) ratio of 4.20x (TTM), a Price-to-Book (P/B) ratio of 1.85x (TTM), at a market cap of $4.67M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 73.21%
Gross Profit Margin TTM: 19.42%
Debt To Equity: 0.69x
P/S TTM: 4.20x
P/B TTM: 1.85x
Market Cap: $4.67M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is 60 DEGREES PHARMACEUTICALS, INC. in?

60 DEGREES PHARMACEUTICALS, INC. (SXTP) operates in the Pharmaceutical Preparations industry.

What is SXTP's market cap?

60 DEGREES PHARMACEUTICALS, INC. (SXTP) has a market capitalization of $4.67M as of 2026-06-30.

What exchange does SXTP trade on?

60 DEGREES PHARMACEUTICALS, INC. (SXTP) trades on the Nasdaq.

Where is 60 DEGREES PHARMACEUTICALS, INC. incorporated?

60 DEGREES PHARMACEUTICALS, INC. is incorporated in DE.